Universitätsklinikum Köln

Hospital


Location: Köln (Cologne), Germany (DE) DE

ISNI: 000000008852305X

ROR: https://ror.org/05mxhda18

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

GeparPiPPa- A randomized, open-label, phase II trial comparing neoadjuvant trastuzumab, pertuzumab and endocrine therapy +/- the PI3K inhibitor inavolisib in patients (pts) with HER2+/HR+, PIK3CA mutant early breast cancer (BC) (2022) Loibl S, Reinisch M, Denkert C, Schneeweiss A, Seiler S, Fasching P, Hanusch C, et al. Conference contribution Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response (2022) Loibl S, Schneeweiss A, Huober J, Braun M, Rey J, Blohmer JU, Furlanetto J, et al. Journal article Prevalence of sport injuries in Olympic combat sports: a cross-sectional study examining one Olympic period (2022) Lambert C, Ritzmann R, Lambert S, Lachmann D, Malliaropoulos NG, Gesslein M, Peters N, Shafizadeh S Journal article Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors (2022) Borchmann S, Selenz C, Lohmann M, Ludwig H, Gassa A, Braegelmann J, Lohneis P, et al. Journal article Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO) (2022) Rogers S, Baumert BG, Blanck O, Boehmer D, Bostroem J, Engenhart-Cabillic R, Ermis E, et al. Journal article Eculizumab use in neuromyelitis optica spectrum disorders: real-world evidence from Germany and Austria (2022) Ringelstein M, Asseyer S, Lindenblatt G, Fischer K, Pul R, Ozalp SH, Lohmann L, et al. Conference contribution Risk of pelvic metastasis and significance of pelvic lymphadenectomy in patients with node-positive vulvar cancer - results of the AGO-VOP.2/QS vulva study (2022) Jaeger A, Hampl M, Zu Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution Long-term survival of HER2-positive breast cancer patients with brain metastases: subanalysis of the BMBC Registry (2022) Laakmann E, Riecke K, Neunhoeffer T, Park-Simon TW, Weide R, Polasik A, Schmidt M, et al. Conference contribution AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022 (2022) Banys-Paluchowski M, Thill M, Kuhn T, Ditsch N, Heil J, Woeckel A, Fallenberg E, et al. Journal article Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages (2022) Royzman D, Peckert-Maier K, Stich L, König C, Wild A, Tauchi M, Ostalecki C, et al. Journal article